Clinical Trial Update: Neonatal Erythropoietin And Therapeutic Hypothermia Outcomes in Newborn Brain Injury (NEATO) [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial NEATO evaluated neonatal erythropoietin with therapeutic hypothermia for brain injury due to hypoxic-ischemic events; study completed with resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Birth Asphyxia
• Hypoxic-ischemic Encephalopathy
• Neonatal Encephalopathy

Drugs mentioned

• Erythropoietin (erythropoietin)
• Therapeutic hypothermia

Snippet

Sponsor: University of California, San Francisco | Conditions: Hypoxic-ischemic Encephalopathy, Neonatal Encephalopathy | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2020-07-13